Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas

Pathology Research and Practice

Volumn 207, Issue 3, 2011, Pages 156-160

  Bayrak, Reyhan ^a   Yenidünya, Sibel ^a   Haltas, Hacer ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

Colon carcinoma; Cytokeratin 20; Cytokeratin 7; Immunohistochemistry

Indexed keywords

AVIDIN; BIOTIN; CYTOKERATIN 20; CYTOKERATIN 7;

ARTICLE; CANCER GRADING; CANCER LOCALIZATION; COLON ADENOCARCINOMA; COLON CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PRIMARY TUMOR; PROTEIN ANALYSIS; RECTUM CARCINOMA; SIGMOID CARCINOMA;

ADENOCARCINOMA; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; TURKEY;

EID: 79952452428     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.12.005     Document Type: Article

References (24)

1. Pecciarini L., Cangi M.G., Doglioni C. Identifying the primary sites of metastatic carcinoma: the increasing role of immunohistochemistry. Curr. Diag. Pathol. 2001, 7:168-175.
2. Varadhachary G.R., Abbruzzese J.L., Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004, 100:1776-1785.
3. Moll R., Werner W., Schiller F.D. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31:11-24.
4. Van Niekerk C.C., Jap P.H., Ramaekers F.C., et al. Immunohistochemical demonstration of keratin 7 in routinely fixed parafin embedded human tissues. J. Pathol. 1991, 165:145-152.
5. Ramaekers F.C., Van Niekerk C.C., Poels L., et al. Use of monoclonal antibodies to keratin 7 in differential diagnosis of adenocarcinomas. Am. J. Pathol. 1990, 136:641-655.
6. Moll R., Lowe A., Laufer J., et al. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am. J. Pathol. 1992, 140:427-447.
7. Wang N.P., Zee S., Zarbo R.J., et al. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl. Immunohistochem. Mol. Morphol. 1995, 3:99-107.
8. Chu P., Wu E., Weiss L.M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod. Pathol. 2000, 13:962-972.
9. Wauters C.C., Smedts F., Gerrits L.G., et al. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum. Pathol. 1995, 26:850-855.
10. Rullier A., Le Bail B., Fawaz R., et al. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinomas metastasis. Am. J. Surg. Pathol. 2000, 24:870-876.
11. Park S.Y., Kim B.H., Kim J.H., et al. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch. Pathol. Lab. Med. 2007, 131:1561-1567.
12. Maeda T., Kajiyama K., Adachi E., et al. The expression of cytokeratins 7, 19, 20 in primary and metastatic carcinomas of the liver. Mod. Pathol. 1996, 9:901-909.
13. Loy T.S., Calaluce R.D. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am. J. Clin. Pathol. 1994, 102:764-767.
14. Zhang P.J., Shah M., Spiegel G.W., et al. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas. Appl. Immunohistochem. Mol. Morphol. 2003, 11:306-310.
15. Ramalingam P., Hart W.R., Goldblum J.R. Cytokeratin subset immunostaining in rectal adenocarcinoma and normal anal glands. Arch. Pathol. Lab. Med. 2001, 125:1074-1077.
16. Saad R.S., Silverman J.F., Khalifa M.A., et al. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma. Appl. Immunohistochem. Mol. Morphol. 2009, 17:196-201.
17. Hamilton S.R., Vogelstein B., Kudo S., et al. Carcinoma of the colon and rectum. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System 2000, 103-143. IARC Press, Lyon, France. S.R. Hamilton, L.A. Aaltonen (Eds.).
18. AJCC Cancer Staging Manual 2009, Springer, New York, NY. 7th ed. S.B. Edge, D.R. Byrd, M.A. Carducci, C.C. Compton (Eds.).
19. Lagendijk J.H., Mullink H., Van Diest P.J., et al. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum. Pathol. 1998, 29:491-497.
20. Loy T.S., Calauce R.D., Keeney G.L. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod. Pathol. 1996, 9:1040-1044.
21. Perry A., Parisi T.T., Kurtin P.J. Metastatic adenocarcinoma to the brain: an immunohistcochemical approach. Hum. Pathol. 1997, 28:938-943.
22. Ikeda S., Fujimori M., Shibala S., et al. Combined immunohistochemistry of beta-catenin, cytokeratin 7 and cytokeratin 20 is useful in discriminating primary lung from metastatic colorectal carcinoma. BMC Cancer 2006, 6:31-36.
23. Hernandez B.Y., Frierson M.F., Moskaluk C.A., et al. CK20 and CK7 protein expression in colorectal carcinoma: demonstration of the utility of a population-based tissue microarray. Hum. Pathol. 2005, 36:275-281.
24. Park S.Y., Kim H.S., Hong E.K., et al. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum. Pathol. 1998, 29:723-728.